Originally at http://feeds.feedblitz.com/~/153025554/0/convinceandconvert~How-the-Recent-Surge-in-Pharma-Deals-is-Dominating-Media-Headlines/

This Week in Realtime Media
Abbott Laboratories Buys St. Jude Medical

Yesterday, it was announced that Abbott Labs would acquire St. Jude Medical in a $25 billion deal to expand heart device research and business. The news of the merger sent Abbott Labs straight to the top of headlines, with a massive spike in mention volume last Thursday morning:

AbbVie Acquires Stemcentrx

In a related industry turn of events, AbbVie Biotherapeutics Corporation (a spin-off of Abbott Laboratories) has decided to expand its oncology presence through the acquisition of Stemcentrx. This $5 billion startup has backing from Silicon Valley investors including Artis Ventures and Founders Fund, and is “in clinical trials of drugs dedesigned to treat cancer by targeting cancer stem cells.”

Unsurprisingly, yesterday was dubbed as Super Thursday in pharmaceutical dealmaking — we then decided to uncover more insights from the acquisitions, while comparing the two side-by-side.

In terms of trending stories, the acquisitions dominated ALL Abbott Labs and AbbVie-related headlines throughout all of Thursday:

<img style="border-width: 1px;border-style: solid" src="https://uberflip.cdntwrk.com/files/aHViPTYxNjQ0JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzU3MjIzYTVmNTQ2NjEuanBnJnZlcnNpb249MDAwMCZzaWc9OWViYzhkNjAzNGJlZjYxZ…

For Your Full SEO Site Report visit http://nationwideseo.com.au/site-report/